Cat.No.: | BSM-0032 |
Product Name: | GSK1070916 |
CAS No.: | 942918-07-2 |
Product Overview: | GSK1070916 is a potent and selective inhibitor of Aurora B/C Kinase with Ki values of 0.38nM and 1.5nM, respectively. GSK1070916 is a reversible ATP-competitive inhibitor of Aurora B and Aurora C with Ki values of 0.38nM and 1.5nM, respectively. The SPA assay shows GSK1070916 has a good selectivity over Aurora A. It inhibits Aurora B with IC50 value of 5nM but 1259nM for Aurora A. It is also reported that treatment of GSK1070916 suppresses cell proliferation in A549 human lung cancer cells with EC50 value of 7nM. Moreover, both in vitro and in vivo assays demonstrate GSK1070916 can inhibit the phosphorylation of histone H3, which is a substrate of Aurora B. GSK1070916 can also suppress tumor growth in mice with HL-60 tumor xenografts. |
Description: | GSK1070916 is a reversible and ATP-competitive inhibitor of Aurora B and C with IC50 value of 3.5 nM and 6.5 nM, respectively. |
Molecular Weight: | 507.63 |
Purity: | >98% |
Storage: | Store at -20°C |
Targets: | Aurora B; Aurora C |
IC50: | 3.5 nM; 6.5 nM |
Molecular Formula: | C30H33N7O |
Chemical Name: | 3-[4-[4-[2-[3-[(dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethylpyrazol-3-yl]phenyl]-1,1-dimethylurea |
Solubility: | Soluble in DMSO > 10 mM |
Shipping Conditions: | Evaluation sample solution: ship with blue ice. All other available size: ship with RT, or blue ice upon request |
Warning: | For Research Use Only! Not For Use in Humans. |
USA
Enter your email here to subscribe.
Follow us on
Easy access to products and services you need from our library via powerful searching tools